当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 利润表

康泰医学

(300869)

  

流通市值:44.75亿  总市值:71.80亿
流通股本:2.50亿   总股本:4.02亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入617,227,119.11494,479,138.73368,699,882.77712,114,538.93
营业收入617,227,119.11494,479,138.73368,699,882.77712,114,538.93
二、营业总成本429,154,337.97311,657,488.01197,193,260.98551,697,858.22
营业成本258,236,909.02191,837,215.01132,298,048.27374,023,325.51
税金及附加10,975,002.668,940,291.446,922,175.6410,055,902.04
销售费用79,095,263.2661,500,820.8834,329,659.1590,212,588.95
管理费用32,395,396.7722,764,010.7914,421,554.0634,435,034.67
研发费用79,806,439.6451,498,174.1525,005,015.8393,253,889.02
财务费用-31,354,673.38-24,883,024.26-15,783,191.97-50,282,881.97
其中:利息费用---19,079,699.93
其中:利息收入---84,274,652.06
加:公允价值变动收益-46,578,258.52-46,629,765.37-22,515,102.3746,636,450.3
加:投资收益57,106,608.7756,072,275.4327,350,274.447,958,625
资产处置收益-5,635.27-5,635.27--259,786.22
资产减值损失(新)-8,493,410.76-7,324,166.02-3,219,087.54-5,844,009.66
信用减值损失(新)333,740.17-291,022.8182,588.79-2,048,350.88
其他收益29,903,988.3326,007,080.8814,999,764.1912,416,103.69
营业利润平衡项目0000
四、营业利润220,339,813.86210,650,417.56188,205,059.3219,275,712.94
加:营业外收入432,275.26128,499.8741,356.68483,350.63
减:营业外支出606,166.98499,823.38311,251.45364,730.83
利润总额平衡项目0000
五、利润总额220,165,922.14210,279,094.05187,935,164.53219,394,332.74
减:所得税费用25,048,367.7127,392,660.6717,883,112.5123,191,774.21
六、净利润195,117,554.43182,886,433.38170,052,052.02196,202,558.53
持续经营净利润195,117,554.43-170,052,052.02196,202,558.53
归属于母公司股东的净利润195,117,554.43182,886,433.38170,052,052.02196,202,558.53
(一)基本每股收益0.490.460.420.49
(二)稀释每股收益0.460.460.420.48
八、其他综合收益1,332,195.881,625,989.34-559,565.392,992,641.92
归属于母公司股东的其他综合收益1,332,195.881,625,989.34-559,565.392,992,641.92
九、综合收益总额196,449,750.31184,512,422.72169,492,486.63199,195,200.45
归属于母公司股东的综合收益总额196,449,750.31184,512,422.72169,492,486.63199,195,200.45
公告日期2023-10-302023-08-302023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑